My original thought on this was, “extremely unlikely”, but since the articles contents were espousing this possibility I thought I would title it this way.
The FLCCC protocols have some red flag items in them that pop up at me. I am unsure in what way Fluvoxamine might be beneficial in anyway to treat what is deemed to be long COVID which seems to have all the hallmarks of an impaired metabolic rate, which includes in its symptoms depression and/or anxiety. Given that their ranks are still trained in the pharmaceutical company funded system, I suppose that they would treat in the way that they know how to.
There is still a lot of money tied up in this new but extremely flawed platform. Given the influence of those invested in this venture, the marketing slogan,”of a needle in every arm”, becomes a government priority when funding to election campaigns is on the line.
But an interesting notion that lawsuits from the survivors of those that passed as a result of the gene therapies or survived but are now injured as a result, as the reason for not offering the COVID-19 shots to those in the employ of the university. I thought that the PREP act might have absolved the University from responsibility for adverse events.
Author
J.R.K